20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Disc Medicine Inc. (IRON) operates in the BIOTECHNOLOGY industry and is headquartered in Watertown, United States with about 165 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, IRON reported $0M in revenue and ($212M) in net income.
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | ($12M) | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Margin % | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($269M) | ($236M) | ($130M) | ($91M) | ($47M) | ($31M) | ($34M) |
| Operating Margin % | 2247.8% | — | — | — | — | — | — |
| Net Income | ($246M) | ($212M) | ($109M) | ($76M) | ($46M) | ($36M) | ($41M) |
| Net Margin % | 2052.6% | — | — | — | — | — | — |
| EBITDA | ($242M) | ($208M) | ($108M) | ($76M) | ($47M) | ($34M) | ($34M) |
| Earnings Per Share (EPS) | $-6.68 | $-6.01 | $-3.96 | $-3.42 | $-44.34 | $-44.88 | $-27.02 |
| Shares Outstanding (M) | 39M | 35M | 28M | 22M | 1M | 1M | 2M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | ($20M) | $8M | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Margin % | — | — | 0.4% | -1.1% | — | — | — | — |
| Operating Income (EBIT) | ($65M) | ($70M) | ($67M) | ($68M) | ($61M) | ($40M) | ($35M) | ($33M) |
| Operating Margin % | — | — | 336.8% | -856.4% | — | — | — | — |
| Net Income | ($60M) | ($64M) | ($61M) | ($62M) | ($55M) | ($34M) | ($29M) | ($27M) |
| Net Margin % | — | — | 304.4% | -788.4% | — | — | — | — |
| EBITDA | ($58M) | ($63M) | ($59M) | ($61M) | ($54M) | ($33M) | ($13M) | ($26M) |
| Earnings Per Share (EPS) | $-1.54 | $-1.65 | $-1.71 | $-1.77 | $-1.58 | $-1.02 | $-0.98 | $-0.89 |
| Shares Outstanding (M) | 39M | 38M | 35M | 35M | 35M | 33M | 30M | 30M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($198M) | ($180M) | ($94M) | ($73M) | ($42M) | ($28M) | ($33M) |
| Capital Expenditures (CapEx) | $0M | $1M | $1M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($198M) | ($181M) | ($94M) | ($74M) | ($42M) | ($28M) | ($33M) |
| FCF Margin % | 1649.4% | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($44M) | ($62M) | ($43M) | ($48M) | ($48M) | ($41M) | ($28M) | ($17M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $1M | $0M | $0M |
| Free Cash Flow (FCF) | ($44M) | ($62M) | ($43M) | ($48M) | ($48M) | ($42M) | ($28M) | ($17M) |
| FCF Margin % | — | — | 217.9% | -605.0% | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Assets | $735M | $807M | $497M | $368M | $200M | $92M | $8M |
| Cash & Cash Equivalents | $99M | $91M | $192M | $360M | $195M | $88M | $5M |
| Total Liabilities | $91M | $67M | $53M | $23M | $24M | $157M | $30M |
| Total Debt (Short + Long-Term) | $60M | $30M | $28M | $1M | $0M | $6M | $22M |
| Total Shareholders' Equity | $644M | $740M | $444M | $345M | $177M | ($64M) | ($22M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IRON viewer.
About TickerBase · Data methodology & sources · Privacy · Terms